SCIL FY26 Annual Report: Record PAT of Rs 543 Cr; leadership transition announced

Ebitda Margin ExpansionResults View source PDF Explain this filing

SUMICHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.0%Reaction day

₹422.50

prior close

₹431.15

announcement price

In-mkt

timing

Nifty Smallcap 250market+0.5%+2.6% vs market

Pesticides & Agrochemicals peers, median of 27sector+0.0%+3.0% vs sector

On the reaction day the stock moved 2.6 pts more than Nifty Smallcap 250 and 3.0 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+1.1

15m

+1.1

30m

+0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.0+0.5+2.6+0.0+3.0

Next day

+4.3+1.5+2.8+1.5+2.8

+18.4+1.6+16.9+1.9+16.6

+14.4+2.0+12.3+1.0+13.3

+11.8+1.3+10.5+0.3+11.5

+10.7-0.7+11.4-0.2+10.8

+21.4+2.2+19.2+1.1+20.3

15d

+26.3+0.8+25.5-0.9+27.1

+22.2+2.5+19.7+1.2+21.1

+21.4+3.6+17.8-5.3+26.7

-0.5-0.7+0.2-11.4+10.8

UpDownMarket · Nifty Smallcap 250Sector · Pesticides & Agrochemicals peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

SCIL FY25-26 revenue rose 3% to Rs 3,238 Cr. Record Profit After Tax of Rs 543 Cr (up 7%, all-time high). EBITDA margin at 20.7% (vs 20.1%), PAT margin 16.8% (vs 16.1%), ROCE at 31% (vs 29%). Company stayed debt-free, net worth up 17% to Rs 3,394 Cr. Dividend of Rs 1.30 per share declared. Herbicides up 19% on strong Lentigo and Mera 71 growth. Leadership shift: Chairman Dr Mukul Asher ends term 31 Aug 2026; MD Chetan Shah to non-executive role; Dr Suresh Ramachandran elevated as MD from 1 Sep 2026. AGM on 27 July 2026.

Likely market impact

Record profits, margin gains, debt-free balance sheet, and steady dividend. Board transition is internal and continuity-led, broadly neutral for shareholders.